Literature DB >> 14531918

Two novel factor V null mutations associated with activated protein C resistance phenotype/genotype discrepancy.

Yesim Dargaud1, Marie C Trzeciak, Sandrine Meunier, Christele Angei, Dorothee Pellechia, Claude Négrier, Christine Vinciguerra, Yesmin Dargaud.   

Abstract

Activated protein C (APC) resistance phenotype/genotype discrepancy is a very rare event. The objective of this study was to characterize the molecular mechanisms in two cases of APC phenotype/genotype discrepancy. An approach using direct sequencing of each exon and splicing junctions of the factor V gene showed that two novel factor V null mutations combined with heterozygous factor V Leiden mutation were responsible for this discrepancy. Our results suggest the necessity to use both phenotypic and genotypic analyses in some cases to determine an accurate diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531918     DOI: 10.1046/j.1365-2141.2003.04620.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Evolving methods for single nucleotide polymorphism detection: Factor V Leiden mutation detection.

Authors:  Herin Oh; Cassandra L Smith
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

2.  A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation.

Authors:  Florian Prüller; Reinhard B Raggam; Harald Mangge; Martie Truschnig-Wilders; Eva-Maria Matzhold; Eva-Christine Weiss; Barbara Hasiba; Kelli L Summers; Wilfried Renner; Gabriele Siegert; Heike Kostka
Journal:  Br J Haematol       Date:  2013-08-19       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.